Ads
related to: ms disease cure- Starting Treatment
Download These Resources To
Help Your Patients Get Started.
- Safety And Vaccine Data
See Data On Long-Term
Safety And Tolerability.
- Dosing & Administration
Discover Dosing Information
For This Treatment.
- Patient Support Services
See Information On Our
Patient Support Program.
- Discover Efficacy Data
Explore Clinical Trial And
Efficacy Data.
- Mechanism Of Action
View This Informational Video
About This Treatment's MOA.
- Starting Treatment
Search results
Results From The WOW.Com Content Network
In March 2017, ocrelizumab was approved in the United States for the treatment of primary progressive multiple sclerosis in adults. [22] [42] It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [42]
The availability of treatments that modify the course of multiple sclerosis beginning in the 1990s, known as disease-modifying therapies (DMTs), has improved prognosis. These treatments can reduce relapses and slow progression, but there is no cure.
There are over 2 million with MS around the world, but when Williams received his official diagnosis back in 1999, not much was known about the disease. Montel Williams opens up about his first ...
Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis.It is a humanized anti-CD20 monoclonal antibody. [8] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. [10]
For premium support please call: 800-290-4726 more ways to reach us
Though MS was first defined by a neurologist in 1868, the medical community still doesn't know what causes it. The disease impacts the central nervous system—the brain, spinal cord, and optic ...
Ads
related to: ms disease cure